Atropine, 0.01%, for Myopia Control

被引：5
|
作者：
Walline, Jeffrey J. J. [1 ]
Berntsen, David A. A. [2 ]
机构：
[1] Ohio State Univ, Coll Optometry, 338 W Tenth Ave, Columbus, OH 43210 USA
[2] Univ Houston, Coll Optometry, Houston, TX USA
来源：
JAMA OPHTHALMOLOGY | 2023年 / 141卷 / 08期
关键词：
D O I：
10.1001/jamaophthalmol.2023.3076
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：766 / 767
页数：2
相关论文
共 50 条
  • [41] Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children
    Cao, Xindan
    Guo, Ziqi
    Wei, Zhiyuan
    Ming, Hongfei
    Ma, Bing
    Zhao, Yue
    Zhang, Yue
    Guo, Lei
    Peng, Cheng
    CONTACT LENS & ANTERIOR EYE, 2025, 48 (01):
  • [42] Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
    Larkin, G. Luke
    Tahir, Alifiya
    Epley, K. David
    Beauchamp, Cynthia L.
    Tong, John T.
    Clark, Robert A.
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (04) : 589 - 598
  • [43] Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control A Randomized Clinical Trial
    Repka, Michael X.
    Weise, Katherine K.
    Chandler, Danielle L.
    Wu, Rui
    Melia, B. Michele
    Manny, Ruth E.
    Kehler, Lori Ann F.
    Jordan, Catherine O.
    Raghuram, Aparna
    Summers, Allison I.
    Lee, Katherine A.
    Petersen, David B.
    Erzurum, S. A.
    Pang, Yi
    Lenhart, Phoebe D.
    Ticho, Benjamin H.
    Beck, Roy W.
    Kraker, Raymond T.
    Holmes, Jonathan M.
    Cotter, Susan A.
    JAMA OPHTHALMOLOGY, 2023, 141 (08) : 756 - 765
  • [44] Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
    Henry H. L. Chan
    Kai Yip Choi
    Alex L. K. Ng
    Bonnie N. K. Choy
    Jonathan Cheuk Hung Chan
    Sonia S. H. Chan
    Serena Z. C. Li
    Wing Yan Yu
    Scientific Reports, 12
  • [45] Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
    Lutz Joachimsen
    Navid Farassat
    Tim Bleul
    Daniel Böhringer
    Wolf A. Lagrèze
    Michael Reich
    International Ophthalmology, 2021, 41 : 2001 - 2008
  • [46] Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
    Joachimsen, Lutz
    Farassat, Navid
    Bleul, Tim
    Boehringer, Daniel
    Lagreze, Wolf A.
    Reich, Michael
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (06) : 2001 - 2008
  • [47] Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
    Chan, Henry H. L.
    Choi, Kai Yip
    Ng, Alex L. K.
    Choy, Bonnie N. K.
    Chan, Jonathan Cheuk Hung
    Chan, Sonia S. H.
    Li, Serena Z. C.
    Yu, Wing Yan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
    Joachimsen, Lutz
    Boehringer, Daniel
    Gross, Nikolai J.
    Reich, Michael
    Stifter, Julia
    Reinhard, Thomas
    Lagreze, Wolf A.
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (03) : 427 - 433
  • [49] Comparison of the Clinical Efficacies of 0.01% Atropine and Orthokeratology in Controlling the Progression of Myopia in Children
    Zhao, Qi
    Hao, Qian
    OPHTHALMIC EPIDEMIOLOGY, 2021, 28 (05) : 376 - 382
  • [50] A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
    Lutz Joachimsen
    Daniel Böhringer
    Nikolai J. Gross
    Michael Reich
    Julia Stifter
    Thomas Reinhard
    Wolf A. Lagrèze
    Ophthalmology and Therapy, 2019, 8 : 427 - 433
12345